More than 75,000 cases comprising more than 1.8 million cartons of consumer level dry eye drops have been voluntarily recalled.

Patients with glaucoma or dry eye disease are likely to have additional systemic conditions that makes self-administration of drops difficult.

The Standardization of Uveitis Nomenclature classification system must be updated to incorporate imaging findings, a task force reports.